Samer Homsi, MD
Pulmonary Disease · Little Rock, ARNPI 1366604902
Payments from drug & device makers
Across 548 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- Mallinckrodt Hospital Products Inc.$538
- Electromed, Inc.$521
- Sanofi$432
- plus $3K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 178 | $2,196 |
| AstraZeneca | 108 | $1,789 |
| Boehringer Ingelheim | 62 | $1,026 |
| Mallinckrodt Hospital Products Inc. | 23 | $538 |
| Electromed, Inc. | 17 | $521 |
| Sanofi | 21 | $432 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $294 |
| Harmony Biosciences LLC | 11 | $280 |
| Regeneron Healthcare Solutions, Inc. | 13 | $252 |
| Mylan Specialty L.p. | 11 | $239 |
| United Therapeutics Corporation | 9 | $212 |
| Insmed, Inc. | 8 | $195 |
| Baxter Healthcare | 9 | $194 |
| Merck | 7 | $143 |
| Viatris Specialty LLC | 5 | $123 |
| Philips North America LLC | 7 | $121 |
| ANI Pharmaceuticals, Inc. | 5 | $100 |
| Genentech USA, Inc. | 6 | $97 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| Amgen | 4 | $78 |
| Verona Pharma, Inc. | 3 | $72 |
| Inspire Medical Systems, Inc. | 1 | $52 |
| CSL Behring | 2 | $52 |
| Grifols USA, LLC | 3 | $50 |
| Vifor Pharma, Inc. | 3 | $50 |
| Intuitive Surgical | 1 | $46 |
| Mallinckrodt Enterprises LLC | 2 | $34 |
| Bayer | 2 | $30 |
| Advanced Respiratory, Inc | 2 | $29 |
| Inogen, Inc. | 2 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| 3b Medical, Inc. | 1 | $17 |
| ERBE USA Inc | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
How this compares
$9,410 in reported general payments places this provider in the 75th percentile of 102 pulmonary disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Little Rock
- Larry JohnsonLittle Rock$847K
- Nikhil MeenaLittle Rock$574K
- Raghu ReddyLittle Rock$541K
- Rajani JaganaLittle Rock$61K
- Hanan Khadam-MakhoulLittle Rock$15K
- Krishna Siva Sai KakkeraLittle Rock$14K
- Eyad AbochaleLittle Rock$11K
- Nathan HillLittle Rock$9K
- Jose CaceresLittle Rock$6K
- Moeezullah BegLittle Rock$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.